• Research To Practice | Oncology Videos

  • By: Dr Neil Love
  • Podcast

Research To Practice | Oncology Videos

By: Dr Neil Love
  • Summary

  • Featuring the video recorded proceedings of events held in conjunction with important scientific symposia, live webcasts and closed meetings featuring the perspectives of renowned clinical investigators, these videos provide an overview of important advances in the management of a number of solid tumors and hematologic cancers.
    Copyright © 2023 Research To Practice. All Rights Reserved.
    Show more Show less
activate_Holiday_promo_in_buybox_DT_T2
Episodes
  • Breast Cancer | Rounds with the Investigators: Compelling Teaching Cases Focused on the Role of Endocrine-Based Therapy in the Management of Breast Cancer
    Jan 3 2025

    Featuring perspectives from Dr Matthew P Goetz, Dr Sara A Hurvitz, Dr Komal Jhaveri, Dr Virginia Kaklamani and Dr Seth Wander, including the following topics:

    • Introduction (0:00)
    • Role of CDK4/6 Inhibitors in Hormone Receptor (HR)-Positive Localized Breast Cancer — Dr Hurvitz (12:21)
    • Incorporation of CDK4/6 Inhibitors into the Management of HR-Positive, HER2-Negative Metastatic Breast Cancer (mBC) — Dr Wander (34:36)
    • Evolving Role of PI3K Inhibitors for HR-Positive mBC Harboring PIK3CA Mutations — Dr Goetz (57:58)
    • Clinical Utility of AKT Inhibitors for Patients with Progressive HR-Positive mBC — Dr Jhaveri (1:15:52)
    • Oral SERDs (Selective Estrogen Receptor Degraders) for HR-Positive mBC — Dr Kaklamani (1:37:24)

    CME information and select publications

    Show more Show less
    2 hrs and 1 min
  • HER2-Low and HER2-Ultralow Breast Cancer | Rounds with the Investigators: Compelling Teaching Cases Focused on the Management of HER2-Low and HER2-Ultralow Breast Cancer
    Dec 23 2024

    Featuring perspectives from Dr Aditya Bardia, Prof Giuseppe Curigliano, Dr Hope S Rugo and Dr Antonio C Wolff, including the following topics:

    • Introduction (0:00)
    • Optimizing the Identification of HER2-Low and HER2-Ultralow Breast Cancer — Dr Wolff (2:28)
    • Available Data with HER2-Targeted Therapy for HER2-Low and HER2-Ultralow Disease — Dr Bardia (23:16)
    • Practical Applications of HER2-Targeted Therapy for HER2-Low and HER2-Ultralow Metastatic Breast Cancer — Prof Curigliano (51:31)
    • Future Directions for HER2-Targeted Therapy for HER2-Low and HER2-Ultralow Breast Cancer — Dr Rugo (1:11:57)

    CME information and select publications

    Show more Show less
    1 hr and 31 mins
  • Multiple Myeloma | What Clinicians Want to Know: Addressing Current Questions and Controversies in the Management of Multiple Myeloma
    Dec 21 2024

    Featuring perspectives from Dr Sagar Lonial, Prof Philippe Moreau, Dr Robert Z Orlowski, Dr Noopur Raje and Dr Paul G Richardson, moderated by Dr Lonial, including the following topics:

    • Introduction (0:00)
    • Management of Newly Diagnosed Multiple Myeloma (MM) — Dr Orlowski (1:26)
    • Integration of Novel Therapies into the Management of Relapsed/Refractory MM — Dr Richardson (26:53)
    • Chimeric Antigen Receptor T-Cell Therapy for MM — Dr Raje (48:48)
    • Bispecific Antibodies for the Treatment of MM — Prof Moreau (1:12:52)
    • Other Novel Agents and Strategies Under Investigation for MM — Dr Lonial (1:36:32)

    CME information and select publications

    Show more Show less
    1 hr and 57 mins

What listeners say about Research To Practice | Oncology Videos

Average customer ratings

Reviews - Please select the tabs below to change the source of reviews.